GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue

Fecha de publicación: 30 de octubre de 2026, 6:48

Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.